Geron Corp (GERN) Enters Global Licensing, Collaboration Agreement with Janssen Covering Telomerase Inhibitor Product Candidate
Tweet Send to a Friend
Geron Corp (Nasdaq: GERN) announced that the company has entered into an exclusive worldwide license and collaboration agreement with Janssen ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
